Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Bay P, Audureau E, Préau S, Favory R, Guigon A, Heming N, et al. COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants. Ann Intensive Care. 2024;14(1):65.
2. Feys S, Hoenigl M, Gangneux JP, Verweij PE, Wauters J. Fungal Fog in Viral Storms: Necessity for Rigor in Aspergillosis Diagnosis and Research. Am J Respir Crit Care Med [Internet]. 2023 Nov 16 [cited 2023 Nov 22]; https://www.atsjournals.org/doi/abs/https://doi.org/10.1164/rccm.202310-1815VP.
3. Feys S, Lagrou K, Lauwers HM, Haenen K, Jacobs C, Brusselmans M et al. High Burden of COVID-19-Associated Pulmonary aspergillosis in severely immunocompromised patients requiring mechanical ventilation. Clin Infect Dis. 2023;ciad546.
4. Gangneux JP, Dannaoui E, Fekkar A, Luyt CE, Botterel F, Prost ND et al. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. The Lancet Respiratory Medicine [Internet]. 2021 Nov 26 [cited 2021 Dec 9];0(0). https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00442-2/fulltext.
5. Pagano L, Busca A, Candoni A, Cattaneo C, Cesaro S, Fanci R, et al. Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations. Blood Rev. 2017;31(2):17–29.